Injective price closed Friday at $4.729, up over 11% on the day and bouncing strongly from support that buyers have held all month. This move was supported by several events: native INJ launched on Coinbase, Thailand’s regulator recently approved a single-asset INJ fund, and July’s Summit added more Wall Street participants.
There is also an unverified X post about a possible staked INJ ETF from Canary Capital, but there is no official confirmation. While this rumor may be helping, the confirmed news is what’s really driving the Injective price.
Coinbase Adds Native INJ as Thai SEC Approves Merkle’s M-INJ Fund
One reason the coin is surging today is that Coinbase, the largest U.S. exchange, will now support native INJ deposits and withdrawals via the Injective EVM. This change removes the need for bridging, making it easier for new users.
Last week in Thailand, Merkle Capital launched M-INJ, Asia’s first single-asset INJ fund approved by the Thai SEC. This gives local investors regulated access to INJ without needing to use exchanges or manage self-custody.
July’s Injective Summit is also strengthening the case for institutional interest. Confirmed attendees include Pantera Capital, Krista Lynch from Grayscale, and Joseph Chalom from Sharplink, who helped shape BlackRock’s digital-asset strategy.
Another reason for today’s surge is strong on-chain data. Helix, a leading Injective DEX, has now reached $77.8 billion in total volume, with $272 million added in the past week. In the last thirty days, over 700 AI agents have joined Injective.
Native USDC is now available as well, and the amount of staked INJ has surpassed 56.6 million. DefiLlama also reported a 55% increase in Injective’s stablecoin cap, now around $18.35 million, with most of it still in Tether’s USDT.
Injective Price Prediction: Key Levels to Watch
Injective opened Friday at $4.275, dipped to $4.175, which was just above the previous low of $4.207, then reached $4.908 before closing at $4.729. This move rejected the lower boundary of the falling wedge that has limited INJ since the $7.30 peak in early June.
Looking at the bigger picture, the chart forms a cup-and-handle pattern: the base near $3.00 from March to April creates the rounded bottom, and the current pullback forms the handle. Both are bullish signs.
Momentum is also improving, but not yet confirmed. The 14-period RSI is at 44.18, below its 50 midline, but it is recovering from the mid-30s. The price still needs to close above the 21-period EMA at $5.021, which remains a key resistance level.
The Injective price prediction hinges on key levels. If the price holds between $4.00 and $4.20 and then moves above $5.02, it could head toward the $6.00 area and the $7.00–$7.30 cup rim, thereby activating the full target. However, if it closes below $4.00, the wedge will break, and the INJ price could fall back into the $3 range.
A single green candle is just an attempt, not a confirmed trend. Injective crypto needs another strong close, a finish above $5.02, and higher trading volume to confirm a move.
READ MORE: Audiera, MemeCore, SKYAI Crypto Tokens are Rising: Beware of a Dead Cat Bounce
